ImmunoDip®: An improved screening method for microalbuminuria

American Journal of Nephrology

Volumn 24, Issue 3, 2004, Pages 284-288

  Davidson, Mayer B ^a   Bazargan, Mohsen ^a   Bakris, George ^b   Harmel, Anne Peters ^c   Campese, Vito ^c   Basta, Emad ^b  

^a CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b Clinical Research Center   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Diabetes hypertension; ImmunoDip screening test; Insulin resistance syndrome; Microalbuminuria; Microalbuminuria, diabetics and hypertensives; NACB screening criteria

Indexed keywords

CREATININE; SERUM ALBUMIN; DIAGNOSTIC AGENT;

ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; EVALUATION; HUMAN; MAJOR CLINICAL STUDY; MICROALBUMINURIA; OUTPATIENT DEPARTMENT; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REFERENCE VALUE; SCREENING TEST; URINALYSIS; ALBUMINURIA; STANDARD; TEST STRIP; URINE;

ALBUMINURIA; HUMANS; REAGENT STRIPS;

EID: 4043104115     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000077854     Document Type: Article

References (32)

1. Mogensen CE: Microalbuminuria as a predictor of clinical diabetic nephropathy. Kidney Int 1987;31:673-689.
2. Viberti GC, Yip-Messent J, Morocutti A: Diabetic nephropathy. Diabetes Care 1992;15:1216-1225.
3. Klein R, Klein BEK, Moss SE: Prevalence of microalbuminuria in older-onset diabetes. Diabetes Care 1993;16:1325-1329.
4. Alzaid AA: Microalbuminuria in patients with NIDDM: An overview. Diabetes Care 1996;19:79-89.
5. Gerstein HC, Mann JF, Pogue J, et al for the HOPE Study Investigators: Prevalence and determinants of MA in high-risk diabetic and nondiabetic patients in the Heart Outcome Prevention Evaluation Study. Diabetes Care 2000;23(suppl 2):B35-B39.
6. Yudkin JS, Forrest RD, Jackson CA: Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Lancet 1988;ii:530-533.
7. Mykkanen L, Zaccaro DJ, Wagenknecht LE, Robbins DC, Gabriel M, Haffner SM: Microalbuminuria is associated with insulin resistance in nondiabetic subjects. Diabetes 1998;47:793-800.
8. DeFronzo RA: Diabetic nephropathy: Etiologic and therapeutic considerations. Diabetes Rev 1995;3:510-564.
9. Marre M, Chatellier G, Leblan H, Guyenne TT, Menard J, Passa P: Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria. BMJ 1988;297:1092-1095.
10. Mathiesen ER, Hommel B, Giese J, Parving HH: Efficacy of captopril in postponing nephropathy in normotensive diabetic patients with microalbuminuria. BMJ 1991;303:81-87.
11. Rudberg S, Aperia A, Freyschuss U, Person B: Enalapril reduces microabuminuria in young normotensive type 1 (insulin-dependent) diabetic patients irrespective of its hypotensive effect. Diabetologia 1990;33:470-476.
12. Viberti GC, Mogensen CE, Groop L, Pauls JF, the European Microalbuminuria Captopril Study Group: Effect of captopril on progression of clinical proteinuria in patients with insulinindependent diabetes mellitus and microalbuminuria. JAMA 1994;271:275-279.
13. Ravid M, Savin H, Jutrin I, Bental T, Katz B, Lishner M: Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients. Ann Intern Med 1993;118:577-581.
14. Sano T, Hotta N, Kawamura T, Matsumae H, Chaya S, Sasaki H, Nakayama M, Hara T, Matsuo S, Sakamoto N: Effects of long-term enalapril treatment on persistent microalbuminuria in normotensive type 2 diabetic patients: Results of a 4-year, prospective, randomized study. Diabet Med 1996;13:120-124.
15. Ravid M, Long R, Rachmani R, Lishner M: Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. Arch Intern Med 1996;156:286-289.
16. The Euclid Study Group: Randomized placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria. Lancet 1997;349:1787-1792.
17. Ravid M, Brosh D, Zohar L, Bar-Dayan Y, Ravid D, Rachmani R: Use of enalapril to attenuate decline in renal function in normotensive, normoalbuminuric patients with type 2 diabetes mellitus. Ann Intern Med 1998;128:982-988.
18. Alberti KGMM, Zimmet PZ for the WHO Consultation: Definition, diagnosis and classification of diabetes mellitus and its complications. 1. Diagnosis and classification of diabetes mellitus: Provisional report of a WHO consultation. Diabet Med 1998;15:539-553.
19. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Pressure: The JNC 7 report. JAMA 2003;289:2560-2572.
20. Gatling W, Knight C, Hill RD: Screening for early diabetic nephropathy: Which sample to detect microalbuminuria? Diabet Med 1985;2:451-455.
21. Eshǿ O, Rasmussen BF, Larsen ML, Mogensen EF: Comparison of overnight, morning and 24-hour urine collections in the assessment of diabetic microalbuminuria. Diabet Med 1987;4:531-533.
22. Ellis D, Coonrod BA, Dorman JS, Kelsey SF, Becker DJ, Avner ED, Orchard TJ: Choice of urine sample predictive of microalbuminuria in patients with insulin-dependent diabetes mellitus. Am J Kidney Dis 1989;13:321-328.
23. Connell SJ, Hollis S, Tieszen KL, McMurray JR, Dornan TL: Gender and the clinical usefulness of the albumin:creatinine ratio. Diabet Med 1994;11:32-36.
24. Chaiken RL, Khawaja R, Bard M, Nortin ME, Banerji MA, Lebovitz HE: Utility of untimed urinary albumin measurements in assessing albuminuria in black NIDDM subjects. Diabetes Care 1997;20:709-713.
25. Zelmanovitz T, Gross JL, Oliveira JR, Paggi A, Tatsch M, Azevedo MJ: The receiver operating characteristics curve in the evaluation of a random urine specimen as a screening test for diabetic nephropathy. Diabetes Care 1997;20:516-519.
26. Bakker AJ: Detection of microalbuminuria. Diabetes Care 1999;22:307-313.
27. Gatling W, Knight C, Mullee MA, Hill RD: Microalbuminuria in diabetes: A population study of the prevalence and an assessment of three screening tests. Diabet Med 1988;5:343-347.
28. Howey JE, Browning MC, Fraser CG: Biologic variation of urinary albumin: Consequences for analysis, specimen collection, interpretation of results, and screening programs. Am J Kidney Dis 1989;13:35-37.
29. National Kidney Foundation: K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification and stratification. Am J Kidney Dis 2002;39(suppl 1):1-266.
30. American Diabetes Association: Diabetic nephropathy. Diabetes Care 2003;26(suppl 1):94-98.
31. Sacks DB, Bruns DE, Goldstein DE, Maclaren NK, McDonald JM, Parrott M: Guides and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 2002;48:436-472.
32. Gaddis GM, Gaddis ML: Introduction to biostatistics. 3. Sensitivity, specificity, predictive value, and hypothesis testing. Ann Emerg Med 1990;145:591-597.